Patricia Murray uncovers the business secrets of the Nobelist Martin Evans and his partner Ajan Reginald. It seems the magic iMP cells used to treat patients in Greece were drawn from the blood of patients in Swansea, for the purpose of a secret PhD thesis. There is no serious science behind it, only serious investor money and a fraudulent patent.
Lynn Kamerlin, Bas de Bruin and their colleagues have been the most vocal critics of Plan S from the very beginning, braving continuous opposition from certain OA leaders. Now that final Plan S guidelines were released, the chemists publish this Open Letter expressing their worry about a possible dystopian OA future.
A UCLA dentistry student writes in a leaked letter: ” I was having disagreements with my research mentor, and thought that Dr. Tetradis could help. Instead, he distorted the issues to attack my mentor, and sexually harassed me. When I filed the Title IX complaint, his powerful colleagues discouraged me from filing.”
A new Open Letter against Plan S appeared on the internet. Presently over 600 scientists are protesting against what they see as a bit totalitarian Open Access initiative by Robert-Jan Smits and his partners from Science Europe. Among the Open Letter signatories are many early career researchers and tenured academics, including two Nobelists.
This is Appeal by several European scientists protesting against Plan S, recently revealed by the EU and a coalition of European research funders. Lynn Kamerlin and her coauthors worry that Plan S will deprive them of quality journal venues and of international collaborative opportunities, while disadvantaging scientists whose research budgets preclude paying and playing in this OA league. They offer instead their own suggestions how to implement Open Science.
Videregen, the Liverpool-based company which bought the trachea regeneration patent from UCL, deployed lawyers against the academics Patricia Murray and Raphael Levy, precisely via their employer University of Liverpool. Main issue is the parliamentary submission by Levy and Murray, subject to absolute privilege. Yet Videregen also cites from the confidential notice of suspected research misconduct Murray and Levy submitted in good faith to UCL.